Artivion, Inc. (AORT) — 分析摘要
Artivion, Inc.(AORT)的市值为1.17十亿美元,最近一年的营收同比增长了+13.6%。净利润率为2.2%。当前市盈率为99.8倍。
核心要点
- 营收同比变化+13.6%
- 净利润率2.2%
- 市盈率99.8倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,AORT的营收增长为+13.6%,市盈率为99.8倍。
Artivion, Inc. (AORT)
更新 — ET · 来源 POLYGON
红旗与风险提示重点关注
当前存在需要关注的风险信号,应与估值结果一并解读。
利息保障倍数为 1.5x — 应对盈利下滑空间有限
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
1,800
总部
KENNESAW, GA
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$0.12
股息收益率
0.52%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。